Erratum: Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK

The article (1) titled “Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK” (doi: 10.21037/jgo-20-533) unfortunately contains errors in Figure 2 and Figure 5.

For Figure 2, during image processing, technical artifacts resulted in misrepresentation of specific protein bands in the Western blot analysis. While this presentation error affects visual clarity, the original experimental data remain unaffected and valid.

For Figure 5, an unintended contrast adjustment during image processing has altered the visual interpretation of immunohistochemistry staining. This technical issue does not compromise the scientific validity of the presented immunohistochemical data.

Figure 2 in the original article:

The correct version of Figure 2 is shown below.

Figure 5 in the original article:

The correct version of Figure 5 is shown below.

Figure 5.

Effect of Asiaticoside (ATS) on the growth, apoptosis, and expression of vimentin and SOX2 protein in transplanted tumor cells in nude mice. Tumor tissue (A) weight and (B) volume. (C) The tumors were stained with TUNEL or indicated antibodies. (D) TUNEL detection of apoptosis rate in transplanted tumor cells and (E) immunohistochemical detection SOX2 positive expression rate. (F) Vimentin positive expression rate detected by immunohistochemistry; compared with 0 mg/kg ATS, *P<0.05.

The authors regret the presence of these two errors and state that they do not affect the scientific conclusions of the article in any manner.

Click here to view the updated version of the article.

Supplementary

The article’s supplementary files as